版本:
中国

BRIEF-Seres Therapeutics Inc Q1 loss per share $0.63

May 4 Seres Therapeutics Inc

* Seres Therapeutics reports first quarter 2017 financial results and provides update on operational progress

* Seres Therapeutics Inc - Q1 loss per share $0.63

* Qtrly total revenue $3.02 million versus $2.71 million

* Q1 earnings per share view $-0.66, revenue view $2.3 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐